Biomaterials used in the posterior segment of the eye
- PMID: 10711963
- DOI: 10.1016/s0142-9612(99)00220-3
Biomaterials used in the posterior segment of the eye
Abstract
The treatment of posterior segment eye disease and related conditions has improved greatly in recent years with the advent of new therapies, materials and devices. Vitreoretinal conditions, however, remain significant causes of blindness in the developed world. Biomaterials play a major role in the treatment of many of these disorders and the success rate of vitreoretinal surgery, especially in the repair of retinal detachment and related conditions, would increase with the introduction of new and improved materials. This review, which focuses on disorders that feature retinal detachment, briefly describes the anatomy of the eye and the nature and treatment of posterior segment eye disorders. The roles, required properties and suitability of the materials used in vitreoretinal surgery as scleral buckles, tamponade agents or drug delivery devices, are reviewed. Experimental approaches are discussed, along with the methods used for their evaluation, and future directions for biomaterial research in the posterior segment of the eye are considered.
Similar articles
-
Artificial vitreous replacements.Biomed Mater Eng. 2003;13(1):59-74. Biomed Mater Eng. 2003. PMID: 12652023 Review.
-
[Gases in vitreoretinal surgery].Cesk Slov Oftalmol. 2012 Feb;68(1):3-8, 10. Cesk Slov Oftalmol. 2012. PMID: 22679691 Review. Slovak.
-
Recent Progress in Using Biomaterials as Vitreous Substitutes.Biomacromolecules. 2015 Oct 12;16(10):3093-102. doi: 10.1021/acs.biomac.5b01091. Epub 2015 Sep 18. Biomacromolecules. 2015. PMID: 26366887 Review.
-
[Early posterior capsule fibrosis after combined cataract and vitreoretinal surgery with intraocular air/SF6 gas tamponade].Klin Monbl Augenheilkd. 1998 Mar;212(3):149-53. doi: 10.1055/s-2008-1034851. Klin Monbl Augenheilkd. 1998. PMID: 9592739 German.
-
Vitreoretinal disease in the coming decade.Curr Opin Ophthalmol. 2010 May;21(3):197-202. doi: 10.1097/ICU.0b013e32833866db. Curr Opin Ophthalmol. 2010. PMID: 20224401 Review.
Cited by
-
An in situ-forming polyzwitterion hydrogel: Towards vitreous substitute application.Bioact Mater. 2021 Mar 9;6(10):3085-3096. doi: 10.1016/j.bioactmat.2021.02.029. eCollection 2021 Oct. Bioact Mater. 2021. PMID: 33778190 Free PMC article.
-
Evaluation of supporting role of a foldable capsular vitreous body with magnetic resonance imaging in the treatment of severe retinal detachment in human eyes.Eye (Lond). 2011 Jun;25(6):794-802. doi: 10.1038/eye.2011.61. Epub 2011 Mar 18. Eye (Lond). 2011. PMID: 21423138 Free PMC article.
-
Comprehensive analysis of inflammatory immune mediators of the intraocular fluid aspirated from the foldable capsular vitreous body filled-eyes.PLoS One. 2012;7(10):e46384. doi: 10.1371/journal.pone.0046384. Epub 2012 Oct 1. PLoS One. 2012. PMID: 23049699 Free PMC article. Clinical Trial.
-
Protein kinase Cα downregulation via siRNA-PKCα released from foldable capsular vitreous body in cultured human retinal pigment epithelium cells.Int J Nanomedicine. 2011;6:1303-11. doi: 10.2147/IJN.S19405. Epub 2011 Jun 22. Int J Nanomedicine. 2011. PMID: 21753881 Free PMC article.
-
Engineering retinal progenitor cell and scrollable poly(glycerol-sebacate) composites for expansion and subretinal transplantation.Biomaterials. 2009 Jul;30(20):3405-14. doi: 10.1016/j.biomaterials.2009.02.046. Epub 2009 Apr 9. Biomaterials. 2009. PMID: 19361860 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources